YU43499A - Crystalline hydrated sodium salt of (e)-4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2- carboxylic acid - Google Patents
Crystalline hydrated sodium salt of (e)-4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2- carboxylic acidInfo
- Publication number
- YU43499A YU43499A YU43499A YU43499A YU43499A YU 43499 A YU43499 A YU 43499A YU 43499 A YU43499 A YU 43499A YU 43499 A YU43499 A YU 43499A YU 43499 A YU43499 A YU 43499A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- sodium salt
- phenylpyrrolidin
- indole
- dichloro
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Kristalna hidratovana natrijumova so (E)-4,6-dihloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline Ovaj pronalazak odnosi se na natrijumovu so jedinjenja formule (1), na postupak za njeno pripremanje, i na njenu primenu u terapiji.The present invention relates to the sodium salt of a compound of formula (1) ), on the procedure for its preparation, and on its application in therapy.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU43499A true YU43499A (en) | 2000-12-28 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU43499A YU43499A (en) | 1997-03-05 | 1998-03-03 | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2- carboxylic acid |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (en) |
| JP (1) | JP2001513796A (en) |
| KR (1) | KR20000075907A (en) |
| CN (1) | CN1249750A (en) |
| AP (1) | AP9901637A0 (en) |
| AR (1) | AR011178A1 (en) |
| AU (1) | AU6825198A (en) |
| BG (1) | BG103779A (en) |
| BR (1) | BR9808305A (en) |
| CA (1) | CA2282851A1 (en) |
| CO (1) | CO4940415A1 (en) |
| EA (1) | EA199900710A1 (en) |
| EE (1) | EE9900387A (en) |
| GB (1) | GB9704498D0 (en) |
| HR (1) | HRP980114A2 (en) |
| HU (1) | HUP0002109A2 (en) |
| ID (1) | ID24207A (en) |
| IL (1) | IL131489A0 (en) |
| IS (1) | IS5166A (en) |
| NO (1) | NO994303L (en) |
| NZ (1) | NZ337315A (en) |
| OA (1) | OA11154A (en) |
| PE (1) | PE51399A1 (en) |
| PL (1) | PL335652A1 (en) |
| SK (1) | SK119699A3 (en) |
| TR (1) | TR199902117T2 (en) |
| WO (1) | WO1998039327A1 (en) |
| YU (1) | YU43499A (en) |
| ZA (1) | ZA981791B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| EP3638234A1 (en) | 2017-06-12 | 2020-04-22 | Glytech LLC. | Treatment of depression with nmda antagonists and d2/5ht2a or selective 5ht2a antagonists |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/en not_active Application Discontinuation
- 1998-03-03 PL PL98335652A patent/PL335652A1/en unknown
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/en unknown
- 1998-03-03 PE PE1998000149A patent/PE51399A1/en not_active Application Discontinuation
- 1998-03-03 AR ARP980100948A patent/AR011178A1/en unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/en unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/en unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/en unknown
- 1998-03-03 YU YU43499A patent/YU43499A/en unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/en active Pending
- 1998-03-03 JP JP53813598A patent/JP2001513796A/en active Pending
- 1998-03-03 ID IDW990976A patent/ID24207A/en unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/en unknown
- 1998-03-03 EE EEP199900387A patent/EE9900387A/en unknown
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/en not_active Application Discontinuation
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Application Discontinuation
- 1998-03-03 IL IL13148998A patent/IL131489A0/en unknown
- 1998-03-03 CO CO98011404A patent/CO4940415A1/en unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/en not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/en unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/en unknown
- 1999-09-03 NO NO994303A patent/NO994303L/en not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO994303D0 (en) | 1999-09-03 |
| KR20000075907A (en) | 2000-12-26 |
| IL131489A0 (en) | 2001-01-28 |
| EA199900710A1 (en) | 2000-04-24 |
| TR199902117T2 (en) | 2000-03-21 |
| ID24207A (en) | 2000-07-13 |
| BG103779A (en) | 2000-06-30 |
| JP2001513796A (en) | 2001-09-04 |
| CO4940415A1 (en) | 2000-07-24 |
| PL335652A1 (en) | 2000-05-08 |
| AU6825198A (en) | 1998-09-22 |
| SK119699A3 (en) | 2000-05-16 |
| ZA981791B (en) | 1999-09-03 |
| NZ337315A (en) | 2001-02-23 |
| EE9900387A (en) | 2000-04-17 |
| OA11154A (en) | 2003-04-16 |
| CN1249750A (en) | 2000-04-05 |
| NO994303L (en) | 1999-11-03 |
| GB9704498D0 (en) | 1997-04-23 |
| IS5166A (en) | 1999-08-27 |
| CA2282851A1 (en) | 1998-09-11 |
| WO1998039327A1 (en) | 1998-09-11 |
| PE51399A1 (en) | 1999-06-07 |
| EP0966463A1 (en) | 1999-12-29 |
| HUP0002109A2 (en) | 2001-04-28 |
| BR9808305A (en) | 2000-05-16 |
| HRP980114A2 (en) | 1998-12-31 |
| AR011178A1 (en) | 2000-08-02 |
| AP9901637A0 (en) | 1999-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199700844T1 (en) | Pyrazolyl-Benzoil T�revleri. | |
| TR200200579T2 (en) | Amino-thyrazolpyridine derivatives. | |
| DE69418461D1 (en) | NEW 5-PYRROLYL-2-PYRIDYLMETHYLSULFINYL BENZIMIDAZOLE DERIVATIVES | |
| EE9900217A (en) | Sulphinic acid derivatives, their preparation and use | |
| YU35697A (en) | Substituted 6,6-hetero-bicyclic derivatives | |
| DK0544819T3 (en) | Indole derivatives which inhibit leukotriene biosynthesis | |
| TR200201668T2 (en) | Peptide-free inhibitors of cell binding due to Vla-4 | |
| CA2260337A1 (en) | Therapeutic agents | |
| MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
| TR199800436A2 (en) | Use of pyrimidine derivatives for cancer prevention. | |
| AU4831899A (en) | 5-HT1F agonists | |
| BR0014651A (en) | Beta2-mediated cell adhesion inhibitors | |
| MY123908A (en) | Meta-azacyclic amino benzoic acid compounds and derivatives thereof | |
| GB9514518D0 (en) | Guanidine salt inhibitors of NO synthase and cyclooxygenase | |
| EP1140900A4 (en) | Pyrazole compounds and uses thereof | |
| TR199700206A2 (en) | Fluoralkyl- and fluoroalkoxy-substituted heterocyclic bradykinin-antagonists, process for their manufacture and their use. | |
| BR9509970A (en) | Compound | |
| AU2135695A (en) | Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments | |
| TR200001909T2 (en) | Matrix metalloprosthesis inhibitors. | |
| MX9702203A (en) | Substituted pyrazolyl-pyrazole derivatives, processes for their preparation and their use as agents with herbicidal action. | |
| YU43499A (en) | Crystalline hydrated sodium salt of (e)-4,6-dichloro-3- (2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2- carboxylic acid | |
| SE9802538D0 (en) | New pharmaceutically active compounds | |
| AU562643B2 (en) | N-arylpiperazine derivatives | |
| PT1104419E (en) | AZABICYCLOHEPTAN DERIVATIVES SUBSTITUTED IN NITROGEN ITS PREPARATION AND UTILIZATION | |
| TR200003570T2 (en) | Mumbaistatin, Production method and pharmaceutical use |